Variables | HR | 95%CI | p value |
---|---|---|---|
Women | Â | Â | 0.863 |
Pre-treatment serum lactate (mmol/L) | 1.47 | 1.02–2.11 | 0.034 |
Pre-treatment WBC (G/L) | Â | Â | 0.670 |
Decreased bowel wall enhancement on pre-treatment CT | 8.28 | 2.07–33.09 | 0.003 |
Complete SMA occlusion | 7.04 | 1.09–45.53 | 0.04 |
Predominant vascular lesion in middle/distal SMA | Â | Â | 0.168 |
Arterial emboli cause | 7.42 | 1.58–34.72 | 0.011 |
Delay initial CT—revascularization (hours) |  |  | 0.272 |
Treatment with thrombolysis | Â | Â | 0.663 |
Treatment with stenting | Â | Â | 0.297 |
Treatment with thrombus-aspiration | Â | Â | 0.153 |